Skip to main content
. 2022 Mar 27;12(4):824. doi: 10.3390/diagnostics12040824

Table 2.

Biological profile comparison between heart failure patients stratified by SARS-CoV-2 infection status.

Variables * Normal Range COVID-19
(n = 124)
% Outside Normality No COVID-19
(n = 236)
% Outside Normality p-Value **
Complete blood count
RBC (millions/mm3) 4.35–5.65 3.46^ (1.6) 61.3% 3.52^ (1.4) 60.2% 0.836
PLT (thousands/mm3) 150–450 98^ (109) 62.1% 103^ (98) 54.2% 0.152
WBC (thousands/mm3) 4.5–11.0 13.1^ (7.5) 48.4% 4.7 (2.9) 20.3.% <0.001
Neutrophils (thousands/mm3) 1.5–8.0 7.4 (4.3) 24.2% 4.9 (3.6) 10.6% <0.001
Monocytes (thousands/mm3) 0.1–1.0 0.3 (0.4) 7.3% 0.6 (0.3) 9.3% 0.794
Eosinophils (units/mm3) 30–300 166 (91) 3.2% 163 (101) 5.1% 0.720
Lymphocytes (thousands/mm3) 1.0–4.8 7.0^ (6.3) 65.3% 2.6 (3.2) 36.9% <0.001
Hemoglobin (g/dL) 13.0–17.0 12.4^ (4.3) 52.4% 12.9^ (5.1) 45.8% 0.318
Hematocrit (%) 36–48 39 (10) 18.5% 40 (12) 16.5% 0.916
MCV (fL) 80–96 87 (92) 30.6% 88 (89) 34.3% 0.644
Liver function tests
Fasting glucose (mmol/L) 60–125 144^ (89) 72.6% 129^ (82) 63.9% 0.029
ALT (U/L) 7–35 59^ (44) 69.4% 45^ (37) 55.9% 0.038
AST (U/L) 10–40 42^ (32) 29.8% 36 (31) 18.2% 0.033
ALP (U/L) 40–130 104 (86) 23.4% 98 (78) 19.5% 0.482
Serum albumin (g/dL) 3.4–5.4 3.7 (1.2) 14.5% 3.8 (1.3) 13.9% 0.663
Total proteins (g/dL) 6.0–8.3 6.3 (3.4) 16.9% 6.3 (2.6) 16.1% 0.908
Total bilirubin (g/dL) 0.3–1.2 1.3^ (0.9) 32.2% 1.1 (0.7) 22.4% 0.062
GGT (U/L) 0–30 28 (19) 23.4% 26 (16) 21.6% 0.154
LDH (U/L) 140–280 241 (135) 16.9% 233 (129) 16.1% 0.891
PT (seconds) 11.0–13.5 14.4^ (7.6) 41.1% 11.3 (4.5) 23.6% <0.001
APTT (seconds) 30–40 39 (11) 21.8% 37 (9) 17.4% 0.128
Inflammatory markers
Procalcitonin (ug/L) 0–0.5 ug/L 0.7^ (0.4) 28.2% 0.5^ (0.3) 25.0% 0.194
CRP (mg/L) 0–10 mg/L 53^ (29) 71.8% 13^ (8) 23.3% <0.001
IL-6 (pg/mL) 0–16 pg/mL 48^ (21) 62.9% 15 (7) 16.5% <0.001
TNF-α (pg/mL) 0–29 pg/mL 43^ (17) 53.2% 22 (10) 15.7% <0.001
IFN-γ (pg/mL) 0–3 pg/mL 3.3^ (1.5) 22.6% 2.8^ (1.3) 17.4% 0.494
ESR (mm/h) 0–22 mm/hr 66^ (28) 68.5% 25^ (13) 27.1% <0.001
Fibrinogen (g/L) 2–4 g/L 6.1^ (2.9) 32.2% 4.1^ (1.1) 19.9% 0.003
D-dimer (ng/mL) <250 348^ (192) 61.3% 244 (97) 19.1% <0.001
BNP (pg/mL) <100 398^ (206) 77.5% 262^ (146) 52.9% <0.001
CK-MB (U/L) 5–25 33^ (14) 33.9% 26^ (8) 22.0% 0.015
LDH (U/L) 140–280 301^ (144) 38.7% 233 (129) 18.6% <0.001
Myoglobin (nmol/L) 1.2–3.6 3.9^ (2.5) 25.0% 3.5 (1.6) 15.3% 0.023
Troponin I (ng/mL) 0–0.4 0.5^ (0.3) 16.3% 0.3^ (0.2) 11.4% 0.040
Troponin T (ng/mL) <14 16^ (12) 30.6% 12 (8) 20.8% 0.037
Kidney function tests
Creatinine (µmol/L) 0.74–1.35 1.66^ (1.69) 63.7% 1.39^ (1.51) 52.5% 0.002
BUN (mmol/L) 2.1–8.5 17^ (12) 71.8% 11^ (9) 61.0% 0.009
Urinary albumin (mg/g) 0–30 43^ (14) 62.9% 40^ (11) 58.8% 0.516
eGFR >60 44^ (30) 69.4% 55^ (24) 54.7% 0.045
Lipid profile
Total cholesterol (mg/dL) 100–200 233^ (65.8) 38.7% 226^ (58.6) 35.6% 0.292
Triglycerides 50–150 163^ (49.7) 27.4% 152^ (42.4) 22.0% 0.326
LDL-C (mg/dL) <100 109.2^ (46.8) 22.6% 106.1^ (43.1) 21.6% 0.694
HDL-C (mg/dL) 40–60 33.0^ (16.1) 25.0% 36.4^ (15.4) 23.3% 0.657

* Data reported as median (IQR) unless specified differently; ** Mann–Whitney U-test; ^ median value outside the normal range; WBC—White Blood Cells; RBC—Red Blood Cells; AST—Aspartate Aminotransferase; ALT—Alanine Aminotransferase; ALP—Alkaline Phosphatase; eGFR—Estimated Glomerular Filtration Rate; LDH—Lactate Dehydrogenase; GGT—Gamma Glutamyl Transpeptidase; BUN—Blood Urea Nitrogen; PT—Prothrombin Time; APTT—Activated Partial Thromboplastin clotting Time; LDL—Low-Density Lipoproteins; HDL—High-Density Lipoproteins; CRP—C-reactive Protein; IL—Interleukin; TNF—Tumor Necrosis Factor; IFN—Interferon; ESR—Erythrocyte Sedimentation Rate; BNP—Brain Natriuretic Peptide; CK-MB—Creatine Kinase—Myoglobin Binding.